| Title |
Effect of NCB-02, Atorvastatin and Placebo on Endothelial Function, Oxidative Stress and Inflammatory Markers in Patients with Type 2 Diabetes Mellitus
|
|---|---|
| Published in |
Drugs in R&D, October 2012
|
| DOI | 10.2165/00126839-200809040-00004 |
| Pubmed ID | |
| Authors |
P. Usharani, A. A. Mateen, M. U. R. Naidu, Y. S. N. Raju, Naval Chandra |
| Abstract |
Hyperglycaemia leads to increased oxidative stress resulting in endothelial dysfunction. ACE inhibitors, antioxidants and HMG-CoA reductase inhibitors (statins) have been shown to improve endothelial function. The aim of this study was to compare the effects of NCB-02 (a standardized preparation of curcuminoids), atorvastatin and placebo on endothelial function and its biomarkers in patients with type 2 diabetes mellitus. |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 33% |
| Unknown | 2 | 67% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 146 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 1% |
| Brazil | 1 | <1% |
| Unknown | 143 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 23 | 16% |
| Student > Bachelor | 22 | 15% |
| Researcher | 17 | 12% |
| Other | 11 | 8% |
| Student > Doctoral Student | 10 | 7% |
| Other | 27 | 18% |
| Unknown | 36 | 25% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 30 | 21% |
| Biochemistry, Genetics and Molecular Biology | 25 | 17% |
| Agricultural and Biological Sciences | 18 | 12% |
| Nursing and Health Professions | 10 | 7% |
| Pharmacology, Toxicology and Pharmaceutical Science | 9 | 6% |
| Other | 13 | 9% |
| Unknown | 41 | 28% |
Attention Score in Context
This research output has an Altmetric Attention Score of 268. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 November 2023.
All research outputs
#134,450
of 25,373,627 outputs
Outputs from Drugs in R&D
#4
of 371 outputs
Outputs of similar age
#598
of 202,127 outputs
Outputs of similar age from Drugs in R&D
#1
of 125 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 371 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.5. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 202,127 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 125 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.